Literature DB >> 2702116

Factors governing urinary tract stone disease.

R W Watts1.   

Abstract

Urinary stone formation depends on the degree of saturation of the urine with respect to potential stone-forming substances. Urine contains a range of electrolytes which ionise to different and variable degrees and which interact with one another in ways which influence their solubilities. These ionisations are themselves influenced by the pH of the urine which is another variable factor. Urinary organic molecules, which may or may not ionise and which may bear surface charges, also influence the solubility of the low molecular weight stone-constituents. Some other substances in the urine, such as glycosaminoglycans, can modify the ability of inorganic micro-crystals to aggregate and form stones. Environmental factors, other urinary tract pathology and genetic influences all predispose to urolithiasis, but many cases lack either an identifiable specific cause or the presence of recognisable risk factors. In the risk factor model of calcium stone formation there are pre-renal risk factors which lead to urinary risk factors and hence to the chemical risk factors of supersaturation and decreased ability to inhibit crystallisation. There are, in addition to these general factors which may act synergistically to produce urinary stones, several specific single enzyme defects which alter the urinary composition in such a way as to produce stones of a highly characteristic composition.

Entities:  

Mesh:

Year:  1989        PMID: 2702116     DOI: 10.1007/BF00858543

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  21 in total

1.  Studies on the treatment of cystinuria.

Authors:  C E DENT; B SENIOR
Journal:  Br J Urol       Date:  1955-12

2.  Immunological heterogeneity of hepatic alanine:glyoxylate aminotransferase in primary hyperoxaluria type 1.

Authors:  P J Wise; C J Danpure; P R Jennings
Journal:  FEBS Lett       Date:  1987-09-28       Impact factor: 4.124

3.  The excretion of amino acids by cystinuric patients and their relatives.

Authors:  J C Crawhall; P Purkiss; R W Watts; E P Young
Journal:  Ann Hum Genet       Date:  1969-10       Impact factor: 1.670

4.  The action of pyridoxine in primary hyperoxaluria.

Authors:  D A Gibbs; R W Watts
Journal:  Clin Sci       Date:  1970-02       Impact factor: 6.124

5.  Enzymological diagnosis of primary hyperoxaluria type 1 by measurement of hepatic alanine: glyoxylate aminotransferase activity.

Authors:  C J Danpure; P R Jennings; R W Watts
Journal:  Lancet       Date:  1987-02-07       Impact factor: 79.321

6.  Heterozygotes for cystinuria.

Authors:  J C Crawhall; E P Saunders; C J Thompson
Journal:  Ann Hum Genet       Date:  1966-03       Impact factor: 1.670

Review 7.  The clinical spectrum of renal tubular acidosis.

Authors:  L L Rocher; R L Tannen
Journal:  Annu Rev Med       Date:  1986       Impact factor: 13.739

8.  Absorptive hyperoxaluria: a new clinical entity--successful treatment with hydrochlorothiazide.

Authors:  E R Yendt; M Cohanim
Journal:  Clin Invest Med       Date:  1986       Impact factor: 0.825

9.  Matrix glycosaminoglycan in urinary stones.

Authors:  S Nishio; Y Abe; A Wakatsuki; H Iwata; K Ochi; M Takeuchi; A Matsumoto
Journal:  J Urol       Date:  1985-09       Impact factor: 7.450

10.  The relation between the concentration of calcium salts in the urine and renal stone composition in patients with calcium-containing renal stones.

Authors:  R W Marshall; M Cochran; W G Robertson; A Hodgkinson; B E Nordin
Journal:  Clin Sci       Date:  1972-09       Impact factor: 6.124

View more
  3 in total

1.  Renal stone disease--investigative aspects.

Authors:  M J Henderson
Journal:  Arch Dis Child       Date:  1993-02       Impact factor: 3.791

2.  Urinary mineral excretion among normal Taiwanese children.

Authors:  Y H Chen; A J Lee; C H Chen; R W Chesney; F B Stapleton; S Roy
Journal:  Pediatr Nephrol       Date:  1994-02       Impact factor: 3.714

3.  Urinary calcium and oxalate excretion in children.

Authors:  G S Reusz; M Dobos; D Byrd; P Sallay; M Miltényi; T Tulassay
Journal:  Pediatr Nephrol       Date:  1995-02       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.